Robotics For Rehabilitation Therapy

Completed

Phase 1/2 Results N/A

Trial Description

The purpose of this study is to develop an upper extremity robotic training system for use by people with stroke to practice arm and hand movement in the clinic.

Detailed Description

Each year in the U.S. over 400,000 people survive a stroke and approximately 80% of acute stroke survivors lose arm and hand movement skills. Movement impairments are typically treated with intensive, hands-on physical and occupational therapy for several weeks after the initial brain injury. Unfortunately, due to economic pressure on the U.S. health care system, stroke patients are receiving less therapy and going home sooner. Our goal for this study is to develop an upper extremity robotic training system for both acute and chronic stroke population to improve movement ability with intensive and repetitive movement in the clinic without continuous supervision from a therapist.

Conditions

Interventions

  • Type I Robotic Group (Functional activities and individual joints) Device
    Intervention Desc: Subjects participate in 11 weeks of robotic training with the device: BONES (Biomimetic Orthosis Neurorehabilitation for Elbow and Shoulder) , 3 days per week, 1 hour per day with the robotic exercise program.
    ARM 1: Kind: Experimental
    Label: 2
    Description: Robotic group (Type II)
  • Type II Robotic therapy (Individual joints only) Device
    Intervention Desc: Subjects participate in 11 weeks of training with the robotic device BONES, 3 days per week, 1 hour per day with a robot-assisted exercise program. The robotic exoskeleton assists in arm and hand movements as the patient plays interactive computer games.
    ARM 1: Kind: Experimental
    Label: 1
    Description: Robotic group(Type I)

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Intervention: Parallel Assignment

Outcomes

Type Measure Time Frame Safety Issue
Primary Motor and strength measure using Box & Block and Fugl-Meyer tests 11 weeks No

Sponsors